Recognition of Research and Development Expenses
First written in FY2018-Q3. 6 of 24 entries say "Restated". Latest entry: FY2026.
90 other companies' latest entry also says "Other".
- FY2026Increase in annual R&D expensesAnnual report
「The total R&D expenses for the consolidated fiscal year were ¥62 million.」
Annual R&D expenses increased from ¥53 million in the previous fiscal year to ¥62 million. - FY2026-H1Increase in interim research and development expensesAnnual report
「The total R&D expenses for the interim consolidated accounting period were ¥31 million.」
Interim R&D expenses were ¥31 million, up from ¥27 million in the same period of the previous year. There were no material changes in the status of R&D activities. - FY2025-H1Interim R&D expenses decreasedAnnual report
「The total R&D expenses for the interim consolidated accounting period were ¥27 million.」
R&D expenses for the interim consolidated accounting period were ¥27 million, down from ¥27.677 million in the same period of the previous year. There were no material changes in the status of R&D activities. - FY2024-Q2R&D expenses decreasedAnnual report
「The total R&D expenses for the cumulative second-quarter period were ¥27.439 million.」
Cumulative R&D expenses for the second quarter were ¥27.439 million, down from ¥27.677 million in the same period of the previous year. There were no material changes in the status of R&D activities. - FY2024-Q1Quarterly R&D expenses decreasedAnnual report
「The total R&D expenses for the cumulative first-quarter period were ¥13.286 million.」
Cumulative R&D expenses for the first quarter were ¥13.286 million, down from ¥13.592 million in the same period of the previous year. - FY2023Annual R&D expenses decreasedAnnual report
「The total R&D expenses for the consolidated fiscal year were ¥52.403 million.」
Annual R&D expenses were ¥52.403 million, down from ¥52.836 million in the previous fiscal year. - FY2023-Q3Cumulative third-quarter R&D expenses increasedAnnual report
「The total R&D expenses for the cumulative third-quarter period were ¥41.644 million.」
Cumulative R&D expenses for the third quarter were ¥41.644 million, up from ¥34.167 million in the same period of the previous year. - FY2023-Q2Increase in R&D SpendingAnnual report
「The total R&D expenses for the cumulative second-quarter period were ¥27.677 million.」
Cumulative R&D expenses for the second quarter were ¥27.677 million, up from ¥25.536 million in the same period of the previous year. There were no material changes in the status of R&D activities. - FY2023-Q1RestatedAnnual report
「The total R&D expenses for the cumulative first-quarter period were ¥13.592 million. There were no material changes in the status of the Group's R&D activities during the cumulative first-quarter period.」
R&D expenses of ¥13.592 million were recorded for the first quarter, with no material changes in R&D activities. - FY2022Increase in annual R&D expensesAnnual report
「The total R&D expenses for the consolidated fiscal year were ¥52.836 million.」
Annual R&D expenses were ¥52.836 million, up from ¥40.920 million in the previous fiscal year. - FY2022-Q3Quarterly R&D expenses decreased year on yearAnnual report
「The total R&D expenses for the cumulative third-quarter period were ¥34.167 million.」
Cumulative R&D expenses for the third quarter were ¥34.167 million, down from ¥34.457 million in the same period of the previous year. There were no material changes in the status of R&D activities. - FY2022-Q2Quarterly R&D expenses decreasedAnnual report
「The total R&D expenses for the cumulative second-quarter period were ¥22.310 million.」
Cumulative R&D expenses for the second quarter were ¥22.310 million, down from ¥25.536 million in the same period of the previous year. There were no material changes in the status of R&D activities. - FY2022-Q1Quarterly R&D expenses decreasedAnnual report
「The total R&D expenses for the cumulative first-quarter period were ¥10.759 million.」
Cumulative R&D expenses for the first quarter were ¥10.759 million, down from ¥11.432 million in the same period of the previous year. There were no material changes in the status of R&D activities. - FY2021-Q3Quarterly R&D expenses decreasedAnnual report
「The total R&D expenses for the cumulative third-quarter period were ¥31.070 million.」
Cumulative R&D expenses for the third quarter were ¥31.070 million, down from ¥34.457 million in the same period of the previous year. There were no material changes in the status of R&D activities. - FY2021-Q2RestatedAnnual report
「The total R&D expenses for the cumulative second-quarter period were ¥20.937 million. There were no material changes in the status of the Group's R&D activities during the cumulative second-quarter period.」
R&D expenses of ¥20.937 million were recorded, with no material changes in R&D activities. - FY2021-Q1Quarterly R&D expenses decreasedAnnual report
「The total R&D expenses for the cumulative first-quarter period were ¥10.842 million.」
R&D expenses for the first quarter were ¥10.842 million, down from ¥11.432 million in the same period of the previous year. There were no material changes in the status of R&D activities. - FY2020Annual R&D expenses decreasedAnnual report
「The total R&D expenses for the consolidated fiscal year were ¥50.146 million.」
Annual R&D expenses were ¥50.146 million, down from ¥50.583 million in the previous fiscal year. - FY2020-Q3RestatedAnnual report
「The total R&D expenses for the cumulative third-quarter period were ¥34.457 million. There were no material changes in the status of the Group's R&D activities during the cumulative third-quarter period.」
R&D expenses of ¥34.457 million were recorded, with no material changes in R&D activities. - FY2020-Q2RestatedAnnual report
「The total R&D expenses for the cumulative second-quarter period were ¥25.536 million. There were no material changes in the status of the Group's R&D activities during the cumulative second-quarter period.」
R&D expenses of ¥25.536 million were recorded, with no material changes in R&D activities. - FY2020-Q1RestatedAnnual report
「There were no material changes in the status of the Group’s research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company has continued to state that there were no significant changes in R&D activities. - FY2019-Q3R&D expenses decreasedAnnual report
「Total R&D expenses for the cumulative consolidated third quarter were ¥35,187 thousand.」
R&D expenses for the cumulative third quarter were ¥35,187 thousand, down from ¥37,212 thousand in the same period of the previous fiscal year. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the cumulative consolidated first quarter were ¥11,432 thousand.」
Quarterly R&D expenses of ¥11,432 thousand were recorded, and no significant changes were reported in R&D activities. - FY2018Increase in R&D SpendingAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥50,583 thousand.」
Annual R&D expenses were ¥50,583 thousand, up from ¥50,413 thousand in the previous fiscal year. - FY2018-Q3First statedAnnual report
「Total R&D expenses for the cumulative consolidated third quarter were ¥37,212 thousand.」
Total R&D expenses for the cumulative consolidated third quarter were disclosed as ¥37,212 thousand.